Back
Vistagen Therapeutics Stock Predictions
Sell
41
VTGN
Vistagen Therapeutics
Last Price:
4.47
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
Vistagen Therapeutics Stock Forecast
-
Is Vistagen Therapeutics Stock Undervalued?
The current Vistagen Therapeutics [VTGN] share price is $4.44. The Score for VTGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal. - VTGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Vistagen Therapeutics Stock Go Up Next Year?
Data Unavailable
Vistagen Therapeutics Stock Rating
Data Unavailable
Vistagen Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vistagen.com
52-Week Data
52-Week High:
24.71
52-Week Low:
1.62
Prediction Charts
Market Cap:
119.99M
Price in USD:
4.44
Volume:
76.92K
Beta:
0.77
Technical Analysis
SMA50:
4.64
SMA100:
4.82
SMA200:
4.70
52-Wk Change:
2.07%
Stock Predictions
-
Is Vistagen Therapeutics stock public?
Yes, Vistagen Therapeutics is a publicly traded company. -
What is the Vistagen Therapeutics stock quote today?
The Vistagen Therapeutics stock price is 4.44 USD today. -
How to buy Vistagen Therapeutics stock online?
You can buy Vistagen Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 4.77 | 4.82 | 4.96 | 4.65 |
| May-1 | 4.85 | 4.72 | 4.93 | 4.72 |
| May-2 | 4.82 | 4.42 | 4.82 | 4.37 |
| May-3 | 4.47 | 4.50 | 4.55 | 4.31 |
| May-6 | 4.55 | 4.60 | 4.67 | 4.53 |
| May-7 | 4.64 | 4.66 | 4.67 | 4.52 |
| May-8 | 4.66 | 4.45 | 4.67 | 4.45 |
| May-9 | 4.51 | 4.47 | 4.58 | 4.39 |
| May-10 | 4.48 | 4.37 | 4.53 | 4.33 |
| May-13 | 4.38 | 4.53 | 4.57 | 4.38 |
| May-14 | 4.55 | 4.52 | 4.75 | 4.50 |
| May-15 | 4.61 | 4.59 | 4.70 | 4.55 |
| May-16 | 4.57 | 4.55 | 4.64 | 4.43 |
| May-17 | 4.56 | 4.44 | 4.57 | 4.44 |
Vistagen Therapeutics Earnings
Data Unavailable
Vistagen Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.08 per share, an increase this year of $6.85 per share, and a decrease next year of $0.43 per share.
* Vistagen Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.